This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
10 Citations
Facts about Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform.
Links G-protein coupled receptor activation to PIP3 production. Involved in immune, inflammatory and allergic reactions.
Human | |
---|---|
Gene Name: | PIK3CG |
Uniprot: | P48736 |
Entrez: | 5294 |
Belongs to: |
---|
PI3/PI4-kinase family |
1-phosphatidylinositol 3-kinase; EC 2.7.1; EC 2.7.1.153; p110-gamma; p120-PI3K; phosphatidylinositol 3 kinase gamma, p110 gamma; phosphatidylinositol 3-kinase catalytic 110-kD gamma; phosphatidylinositol 3-kinase, catalytic, gamma polypeptide; Phosphatidylinositol-4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform; phosphoinositide-3-kinase gamma catalytic subunit; phosphoinositide-3-kinase, catalytic, gamma polypeptide; PI 3Kinase p110 gamma; PI 3-Kinase p110 gamma; PI3CG; PI3K; PI3K-gamma ; PI3Kgamma; PI3K
Mass (kDA):
126.454 kDA
Human | |
---|---|
Location: | 7q22.3 |
Sequence: | 7; NC_000007.14 (106865282..106908980) |
Pancreas, skeletal muscle, liver and heart.
Cytoplasm. Cell membrane.
This article will examine Boster Bio and the PIK3CG marker. Additionally it will discuss IGF2 and the PI3K gamma. PIK3CG is an indicator for the kinase PIK3C which is a key factor in the creation of IGF2. This article will help you make informed decisions regarding whether you're looking for a PIK3CG anti-body or an IGF2 inhibitor.
The PIK3CG gene encodes an enzyme which phosphorylates the phosphoinositides. Numerous single nucleotide variants in this gene have clinical significance. The most notable is rs342286 located 140 kb to the right of the PIK3CG gene. In the past, SNPs located near PIK3CG have been associated with an increase in platelet aggregation. Recently, Wain et al. A new locus (30) was identified close to PIK3CG.
The PIK3CG gene is an important target for therapeutic drugs. Boster Bio offers highly specific and high-affinity anti-mAbs that target this PIK3CG target. This mAb is extensively cited by the scientific community and has been tested using ELISA, Western Blotting, and Immunohistochemistry techniques. It is highly specific and highly sensitive, which allows researchers to carry out a variety of applications.
The PI3K-a kinase is a kinas ATP phosphate in a similar way to the PI3K g marker. However, the PI3K-a kinase also has two docking locations one at the nucleotide end and the one located at the protein's C -terminus. To form hydrogen bonds with Val 851 near the nucleotide's end Both docking sites require three hydroxyl groups.
Del blocks Akt and PI3K activity in NHEK cell. It blocks Akt/PI3K/Akt/mTOR activity and reduces the production of proinflammatory cytokines. It is a p–gpik inhibitor that has a wide range of applications. The best uses of the marker PIK3CG
IGFs are well-known to regulate PI3K/Akt signaling by activating IGF1R. IGF2 is an inhibitor of PI3K-Akt activity in these cells, and PIK3CG is among the most well-known targets of this signaling pathway. The PI3K-Akt pathway is the main regulator of cell proliferative capacity. It is crucial to keep in mind that IGF2 overexpression can negatively impact PI3K3CG transcription.
The catalytic subunit of the PI3K protein is encoded by the PIK3CG gene. PIK3CG is extremely expressed in the aortas of human lesions and in mouse models of AS. Studies have also proven that a PIK3CG-specific inhibitor slowed the development AS in LDLR mice. PIK3CG is a key regulator of HDL clearance.
The PIK3CG marker has a myriad of applications. It can be used to detect and analyze PIK3G-deficient mice that reproduce the symptoms of human diseases. The gene is crucial for encouraging adaptive immune responses as well as reducing inflammation. Although these findings are encouraging, future studies need to confirm their use in human clinical trials. There is the PIK3CG gene in a variety of tissues. The best method for analyzing it is to examine the expression patterns in human tissues.
One study that was conducted on mice revealed several mutations in the PIK3CG gene. This study revealed that the gene was controlled by miR146b-3p. Mice treated with miR146b-3p mimics showed a decrease in gene expression. Immunopathology was observed in mice model that were PIK3CG-deficient. It also showed decreased expression of other immune genes.
As a potential therapeutic target for atherosclerosis, the PIK3CG gene was identified. In mice that lack PIK3CG, the expression of macrophage markers M2 was decreased. In addition, mice with impaired PIK3CG expression showed increased insulin resistance and decreased inflammation. These findings suggest that the PI3Kg gene could be a therapeutic target for diabetes.
PMID: 7624799 by Stoyanov B., et al. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase.
PMID: 11416136 by Gu C., et al. The EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity- independent manner.
*More publications can be found for each product on its corresponding product page